Imprint, an organization founded at Cornell Tech that is dedicated to decoding the body’s immune memory and uncovering the causes of chronic diseases, announced that it has raised over $15 million in funding.
A new artificial intelligence-based method accurately sorts cancer patients into groups that have similar characteristics before treatment and similar outcomes after treatment, according to a study led by investigators at Weill Cornell Medicine.
Researchers at Weill Cornell Medicine have discovered that a parasite that causes malaria when transmitted through a mosquito bite can shut down a key set of genes, rendering itself “immunologically invisible” — sometimes for years.
Using machine learning technology, a new study has identified three distinct profiles describing social and economic factors that are associated with a higher risk of suicide.
A total of 450 expected graduates in the Class of 2025 received their degrees from Weill Cornell Medicine during the institution’s annual Commencement ceremony, held May 15 at Carnegie Hall.
Weill Cornell Medicine has received a projected $4 million grant to conduct a clinical trial testing whether a new imaging approach could reduce the need for biopsies to monitor prostate cancer.
Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the injectable drugs.
Weill Cornell Medicine and colleagues in Tanzania are fostering a new generation of M.D./Ph.D. researchers, with implications for improved health care outcomes worldwide.
